You are here:
Two key factors set the Vaccine Alliance apart from other actors in the field of international health aid:
In this section, we explain Gavi’s unique business model and the six ways it delivers "added value".
Donor and developing countries need to see proof of the value of new vaccines before investing.
Immunisation is a commitment for life that requires guaranteed, long-term funding.
Developing countries decide for themselves how best to use Gavi support for immunisation.
It's not enough to buy new vaccines. They have to safely reach every child.
Manufacturers will only make vaccines for poor countries if they know they can sell them .
National immunisation programes must survive long after Gavi support stops.
Gavi support will assist countries to immunise a further 243 million children between 2011 and 2015.
19 February 2015
27 January 2015
Donors pledge record $7.5B for global vaccines program
The Daily Mail
22 January 2015
A Birthday Gift to Last a Lifetime
The Huffington Post
11 January 2015
The United States should generously support Gavi's immunization efforts
The Washington Post
06 January 2015
Gates Foundation Uses Art to Encourage Vaccination
The New York Times
18 December 2014
A global conspiracy of health
05 December 2014
Ebola Vaccines: Why Clinical Trials Are Just the First Step
04 December 2014
An Important Step in Congress for Protecting Children’s Health
02 October 2013
Laos becomes first South East Asian nation to introduce pneumococcal vaccine
04 May 2013
Sojo Stories: Immunizing 250 Million Children By 2015
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2015
modal window here